The body relies on blood to deliver fuel and oxygen to its billions of cells and to combat infections and other diseases. For these reasons, blood disorders can impact a host of bodily functions. The doctors at Seattle Cancer Care Alliance (SCCA) treat a wide range of blood disorders using leading-edge therapies with an eye to providing care to you as a whole person.
Expert diagnosis and treatment
Many blood disorders are rare and treating them can be difficult. SCCA hematologists and oncologists have the expertise to diagnose and treat even the most complex or uncommon conditions. In addition to blood-related cancers, like leukemia, Hodgkin’s and non-Hodgkin’s lymphoma, and multiple myeloma, we see patients with myelodysplastic syndrome, myeloproliferative neoplasms, and many types of nonmalignant (noncancerous) blood disorders, including aplastic anemia, inherited bone marrow failure syndromes, deep vein thrombosis, and sickle cell disease.
See a more complete list of blood disorders treated by SCCA doctors.
Most experienced transplant center
For people who have been diagnosed with certain blood diseases, a bone marrow transplant can offer the best hope. The Fred Hutch Blood and Bone Marrow Transplant Program at SCCA is a leading provider of bone marrow transplants for both blood cancers and nonmalignant blood disorders. Our doctors have performed more than 14,000 bone marrow transplants—more than any institution in the world. Our success rates are also among the best, measured in terms of one-year survival rates of our patients.
Clinical study opportunities
SCCA was formed, in part, to bring promising new treatments to patients faster. For people with blood disorders, this means more treatment options through SCCA than you might find elsewhere, including the chance to participate in one of many ongoing clinical studies conducted at SCCA and its founding organizations, Fred Hutch and UW Medicine. Find out more about participating in a study.
Hematologic Malignancy Genetics Clinic
SCCA is one of only a few cancer centers in the nation to offer a Hematologic Malignancy Genetics Clinic. This program offers personalized risk assessment and follow-up care for adult patients and family members who may be at increased risk for developing hematologic malignancies due to an underlying genetic cause.
To schedule an appointment with the SCCA Hematologic Malignancy Genetics Clinic, call 1 (855) 557-0555.
Patients at risk for an inherited hematologic malignancy fit one of the following criteria:
- Have a personal or family history of long-standing blood count abnormalities of unknown cause
- Have a personal history of a blood cancer with close relative(s) who also have blood cancers
- Were diagnosed with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) before the age of 45
- Have a known familial marrow failure syndrome or an inherited predisposition to hematologic malignancy such as:
- Familial platelet disorder with propensity to myeloid malignancies (e.g., RUNX1 mutation)
- Familial MDS/AML (e.g., GATA2 mutation)
- Other known familial MDS/acute leukemia predisposition syndrome
- Telomere biology disorder or other inherited bone marrow failure condition (e.g., Diamond Blackfan anemia, Shwachman Diamond Syndrome)
- Have been referred to our clinic for evaluation by their provider
A visit to our hematologic malignancy genetics clinic includes the following services:
- Cancer risk assessment and genetic testing
- Cancer prevention counseling and strategies
- Evaluation to inform optimal hematopoietic stem cell transplant donor selection and preparatory regimen
- Long-term follow-up
The clinic is staffed by hematologist Siobán Keel, MD, medical geneticist Marshall Horwitz, MD, PhD, genetic counselor Mercy Laurino, MS, CGC, PhD and hematology nurse Amanda Weatherford, MS, RN, OCN.